Overall, asthma mortality rates have declined dramatically in the last 30 years, due to
improved diagnosis and to better treatment, particularly in the 1990s following the more …

Fractional exhaled nitric oxide (FeNO) is the only available point of care test to assess type-2
inflammation in asthma. In making a diagnosis of asthma, FeNO should be used together …

Background Assessment of asthma using clinical measures alone often fails to detect
underlying airway inflammation. Fractional exhaled nitric oxide (FeNO) is a recognized …

Background High bronchodilator reversibility in adult asthma is associated with distinct
clinical characteristics. In this study, we aim to make a comparison with T-helper 2 (Th2) …

Bronchial hyperresponsiveness (BHR) is defined as a heightened bronchoconstrictive
response to airway stimuli. It complements the cardinal features in asthma, such as variable …

Over use of reliever as short acting beta-agonist (SABA) and associated underuse of
controller as inhaled corticosteroid (ICS) administered via separate inhalers results in worse …

Introduction Inhaled corticosteroids (ICS) are known to increase the risk of systemic and
local adverse effects, especially with high doses and long-term use. Hence, considerable …

摘要目的: 探讨吸入激素治疗哮喘-慢阻肺重叠综合征(ACOS) 患者的临床疗效及对内皮细胞功能
的影响. 方法: 收集2013 年3 月至2016 年3 月在我院接受治疗的95 例ACOS 患者 …

During the past decade, there has been an explosion in our knowledge of asthma. There are
new descriptions of phenotypes, endotypes, and even genotypes. New approaches to …

Despite great advances in our understanding and treatment of asthma, significant morbidity
and mortality persist. Recent statistics have reported 1.8 million emergency department visits …